IBM releases novel AI-powered technology to accelerate medical research for COVID-19

IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery. These novel resources, from across IBM and available beginning today (Friday 3 April)...

Keeping Cool in a Global Pandemic

By Sonia Houghton, CEO, Cryosphere As Covid-19 spreads across the globe and governments worldwide are desperately trying to heed learnings from how China, Italy and other countries have managed the containment of the virus, the...

Safe’n’Spray™, the smart electronic concept device with child-resistant and locking features, wins the ‘Best...

A team of industry experts awarded Nemera’s Safe’n’Spray with a prestigious Pharmapack Award for ‘Best Innovation in Drug Delivery Device’. On February 5th, during the Pharmapack Awards Ceremony, Safe’n’Spray, Nemera’s smart electronic concept device with...

UK offers accelerated patent protection for eco-friendly innovations

Using the Green Channel to accelerate a UK patent application. AdamsonJones was able to obtain patent protection for client, LLEO Ltd, in just 15 months from the moment the Green Channel was used. This acceleration was crucial as...

Bionic hand made in 10 hours thanks to WMG, University of Warwick

A 3D printed bionic hand can be made to measure thanks to engineers at WMG, University of Warwick and a collaboration of other companies. The 3D printed hand incorporates muscle sensors to...

Project to predict cardiovascular events receives Heart Research UK grant

A project at the University of Manchester aiming to develop a new tool for predicting the risk of a cardiovascular event or death in patients who have already suffered a heart attack has received...

Good blood supply in fat could explain ‘fat but fit’ paradox

Improving blood supply to fat could help to prevent heart disease. The ‘fat but fit’ paradox – where some people who are overweight have a seemingly healthy metabolism – may be explained by a good...

Testosterone levels affect risk of metabolic disease and cancers

Having genetically higher testosterone levels increases the risk of metabolic diseases such as type 2 diabetes in women, while reducing the risk in men. Higher testosterone levels also increase the risks of breast and...

Skin cancer diagnosis apps are unreliable and poorly regulated

Smartphone apps used as ‘early warning systems’ for skin cancer are poorly regulated and frequently cannot be relied upon to produce accurate results, according to new analysis by experts at the University of Birmingham. Skin...

Edible insects: Mealworms on your menu?

Cricket brownies and “chocolate chirp cookies” were served at a meeting about the future of edible insects. Insects are eaten in many parts of the world, and if people in countries such as the UK...

NEW TECHNIQUE ALLOWS SCIENTISTS TO ‘LISTEN IN’ ON CANCER CELLS

Scientists have a developed a new technique to decipher how millions of individual cells are communicating with each other in miniature tumours grown in the lab, known as organoids, according to new research published...

How the brain’s immune system could be harnessed to improve memory

When it comes to memory, immune cells are known as the “bad cops” of the brain. But new research shows they could also be turned into “good cops” to power memory and learning. Inflammation can...

Betrayed by bile: bile acids help norovirus sneak into cells

A new study led by researchers at Baylor College of Medicine and published in the Proceedings of the National Academy of Sciences reveals that human noroviruses, the leading viral cause of foodborne illness and...

Newcastle based company addresses key challenge to the success of lab-grown meat

With a predicted world population reaching just short of 10 billion by 2050 (3 billion more than there were in 2010), developing efficient, environmentally friendly and affordable food production technologies becomes a real challenge....

UK accounts for over 12% of global cell and gene therapy clinical trials

The UK and the NHS are providing the right environment and infrastructure to allow innovative cell and gene therapies to reach patients. International companies recognise the appeal of the UK cell and gene therapy...

New Cell and Gene Therapy Catapult CEO brings continuity and ambition

Matthew Durdy appointed to CEO role as the CGT Catapult prepares to accelerate innovation, growth and productivity, where needed in the UK. The Board of the Cell and Gene Therapy Catapult (CGT Catapult), a global...